Clinical Trials Browser

zanidatamab × Genitourinary × 1 year × Clear all

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Esophageal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07296705 2025-12-22

HARBOR

Phase 2 Recruiting

25 enrolled

Genitourinary

Muscle Invasive Bladder Cancer (MIBC)

Clinical Trials

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

HARBOR